S. DEMİREL Et Al. , "Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study," OPHTHALMIC RESEARCH , vol.56, no.1, pp.35-40, 2016
DEMİREL, S. Et Al. 2016. Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study. OPHTHALMIC RESEARCH , vol.56, no.1 , 35-40.
DEMİREL, S., Bilici, S., ŞERMET, F., & ÖZMERT, E., (2016). Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study. OPHTHALMIC RESEARCH , vol.56, no.1, 35-40.
DEMİREL, SİBEL Et Al. "Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study," OPHTHALMIC RESEARCH , vol.56, no.1, 35-40, 2016
DEMİREL, SİBEL Et Al. "Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study." OPHTHALMIC RESEARCH , vol.56, no.1, pp.35-40, 2016
DEMİREL, S. Et Al. (2016) . "Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study." OPHTHALMIC RESEARCH , vol.56, no.1, pp.35-40.
@article{article, author={SİBEL DEMİREL Et Al. }, title={Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study}, journal={OPHTHALMIC RESEARCH}, year=2016, pages={35-40} }